792 OUTCOMES AFTER TOTALLY MINIMALLY INVASIVE VERSUS HYBRID OR OPEN IVOR LEWIS ESOPHAGECTOMY: RESULTS FROM THE INTERNATIONAL ESODATA STUDY GROUP.
Berend Van Der Wilk(Erasmus MC), Mark I. van Berge Henegouwen(University of Namur), Suzanne S. Gisbertz(Dutch Cancer Society), Richard van Hillegersberg(University Medical Center Utrecht), Philippe Nafteux(KU Leuven), Eliza Hagens(University of Amsterdam), Sjoerd M. Lagarde(University of Amsterdam), Ben M. Eyck(Erasmus MC Cancer Institute), Magnus Nilsson(Karolinska University Hospital), Wolfgang Schröder(University of Cologne), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute)
Cited by 0
Related Papers
Gastric cancer
|The Lancet|2020|4.8k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus
|Annals of Surgery|2007|709
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|646